Physician profile
Brett Owens
NPI 1467443051
$272,758.57
in general payments reported to CMS, 2019-2025
5 companies · $74K in 2025
The $74K reported for 2025 was more than what 96% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $13K · 2021: $16K · 2022: $26K · 2023: $74K · 2024: $59K · 2025: $74K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $194K · Consulting Fee: $13K · Travel and Lodging: $573 · Food and Beverage: $22.03 · Education: $21.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $193,513.42 |
| Consulting Fee | $12,705.00 |
| Travel and Lodging | $573.39 |
| Food and Beverage | $22.03 |
| Education | $21.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $253,171.80 | 2019-2025 | Infinity Knee System, Ezstart |
| Depuy Synthes Products, INC. | $13,319.17 | 2019-2023 | Fms, Velys |
| Vericel Corporation | $2,589.33 | 2020-2023 | Maci |
| Musculoskeletal Transplant Foundation INC. | $2,500.00 | 2019 | |
| Medical Device Business Services, INC. | $1,178.27 | 2022-2023 | Fms |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Owens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.